Global Radiopharmaceutical Market Insights, Forecast to 2025

1 Study Coverage

• 1.1 Radiopharmaceutical Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type
  • 1.2.2 Actinium-225
  • 1.2.3 Lutetium-177
  • 1.2.4 Radium-223
  • 1.2.5 Holmium-166
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application
  • 1.3.2 Oncology
  • 1.3.3 Cardiology
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Radiopharmaceutical Market Size Estimates and Forecasts
  • 2.1.1 Global Radiopharmaceutical Revenue 2015-2026
  • 2.1.2 Global Radiopharmaceutical Sales 2015-2026
• 2.2 Radiopharmaceutical Market Size by Region: 2020 Versus 2026
• 2.3 Radiopharmaceutical Sales by Region (2015-2026)
  • 2.3.1 Global Radiopharmaceutical Sales by Region: 2015-2020
  • 2.3.2 Global Radiopharmaceutical Sales Forecast by Region (2021-2026)
  • 2.3.3 Global Radiopharmaceutical Sales Market Share by Region (2015-2026)
• 2.4 Radiopharmaceutical Market Estimates and Projections by Region (2021-2026)
  • 2.4.1 Global Radiopharmaceutical Revenue by Region: 2015-2020
  • 2.4.2 Global Radiopharmaceutical Revenue Forecast by Region (2021-2026)
  • 2.4.3 Global Radiopharmaceutical Revenue Market Share by Region (2015-2026)

3 Global Radiopharmaceutical by Manufacturers

• 3.1 Global Top Radiopharmaceutical Manufacturers by Sales
  • 3.1.1 Global Radiopharmaceutical Sales by Manufacturer (2015-2020)
  • 3.1.2 Global Radiopharmaceutical Sales Market Share by Manufacturer (2015-2019)
• 3.2 Global Top Radiopharmaceutical Manufacturers by Revenue
  • 3.2.1 Global Radiopharmaceutical Revenue by Manufacturer (2015-2020)
  • 3.2.2 Global Radiopharmaceutical Revenue Share by Manufacturer (2015-2020)
• 3.3 Global Radiopharmaceutical Price by Manufacturer (2015-2020)
• 3.4 Competitive Landscape
  • 3.4.1 Key Radiopharmaceutical Manufacturers Covered: Ranking by Revenue
  • 3.4.2 Global Radiopharmaceutical Market Concentration Ratio (CR5 and HHI) & (2015-2020)
  • 3.4.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.5 Global Radiopharmaceutical Manufacturing Base Distribution, Product Type
  • 3.5.1 Radiopharmaceutical Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.5.2 Manufacturers Radiopharmaceutical Product Type
  • 3.5.3 Date of International Manufacturers Enter into Radiopharmaceutical Market
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

• 4.1 Bracco Imaging
  • 4.1.1 Bracco Imaging Corporation Information
  • 4.1.2 Bracco Imaging Description, Business Overview
  • 4.1.3 Bracco Imaging Radiopharmaceutical Products Offered
  • 4.1.4 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.1.5 Bracco Imaging Radiopharmaceutical Revenue by Product
  • 4.1.6 Bracco Imaging Radiopharmaceutical Revenue by Application
  • 4.1.7 Bracco Imaging Radiopharmaceutical Revenue by Geographic Area
  • 4.1.8 Bracco Imaging Radiopharmaceutical Revenue by Sales Channel
  • 4.1.9 Bracco Imaging Recent Development
• 4.2 Bayer
  • 4.2.1 Bayer Corporation Information
  • 4.2.2 Bayer Description, Business Overview
  • 4.2.3 Bayer Radiopharmaceutical Products Offered
  • 4.2.4 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.2.5 Bayer Radiopharmaceutical Revenue by Product
  • 4.2.6 Bayer Radiopharmaceutical Revenue by Application
  • 4.2.7 Bayer Radiopharmaceutical Revenue by Geographic Area
  • 4.2.8 Bayer Radiopharmaceutical Revenue by Sales Channel
  • 4.2.9 Bayer Recent Development
• 4.3 Mallinckrodt
  • 4.3.1 Mallinckrodt Corporation Information
  • 4.3.2 Mallinckrodt Description, Business Overview
  • 4.3.3 Mallinckrodt Radiopharmaceutical Products Offered
  • 4.3.4 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.3.5 Mallinckrodt Radiopharmaceutical Revenue by Product
  • 4.3.6 Mallinckrodt Radiopharmaceutical Revenue by Application
  • 4.3.7 Mallinckrodt Radiopharmaceutical Revenue by Geographic Area
  • 4.3.8 Mallinckrodt Radiopharmaceutical Revenue by Sales Channel
  • 4.3.9 Mallinckrodt Recent Development
• 4.4 Nordion
  • 4.4.1 Nordion Corporation Information
  • 4.4.2 Nordion Description, Business Overview
  • 4.4.3 Nordion Radiopharmaceutical Products Offered
  • 4.4.4 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.4.5 Nordion Radiopharmaceutical Revenue by Product
  • 4.4.6 Nordion Radiopharmaceutical Revenue by Application
  • 4.4.7 Nordion Radiopharmaceutical Revenue by Geographic Area
  • 4.4.8 Nordion Radiopharmaceutical Revenue by Sales Channel
  • 4.4.9 Nordion Recent Development
• 4.5 Triad Isotopes
  • 4.5.1 Triad Isotopes Corporation Information
  • 4.5.2 Triad Isotopes Description, Business Overview
  • 4.5.3 Triad Isotopes Radiopharmaceutical Products Offered
  • 4.5.4 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.5.5 Triad Isotopes Radiopharmaceutical Revenue by Product
  • 4.5.6 Triad Isotopes Radiopharmaceutical Revenue by Application
  • 4.5.7 Triad Isotopes Radiopharmaceutical Revenue by Geographic Area
  • 4.5.8 Triad Isotopes Radiopharmaceutical Revenue by Sales Channel
  • 4.5.9 Triad Isotopes Recent Development
• 4.6 Lantheus
  • 4.6.1 Lantheus Corporation Information
  • 4.6.2 Lantheus Description, Business Overview
  • 4.6.3 Lantheus Radiopharmaceutical Products Offered
  • 4.6.4 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.6.5 Lantheus Radiopharmaceutical Revenue by Product
  • 4.6.6 Lantheus Radiopharmaceutical Revenue by Application
  • 4.6.7 Lantheus Radiopharmaceutical Revenue by Geographic Area
  • 4.6.8 Lantheus Recent Development
• 4.7 IBA Group
  • 4.7.1 IBA Group Corporation Information
  • 4.7.2 IBA Group Description, Business Overview
  • 4.7.3 IBA Group Radiopharmaceutical Products Offered
  • 4.7.4 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.7.5 IBA Group Radiopharmaceutical Revenue by Product
  • 4.7.6 IBA Group Radiopharmaceutical Revenue by Application
  • 4.7.7 IBA Group Radiopharmaceutical Revenue by Geographic Area
  • 4.7.8 IBA Group Recent Development
• 4.8 GE Healthcare
  • 4.8.1 GE Healthcare Corporation Information
  • 4.8.2 GE Healthcare Description, Business Overview
  • 4.8.3 GE Healthcare Radiopharmaceutical Products Offered
  • 4.8.4 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.8.5 GE Healthcare Radiopharmaceutical Revenue by Product
  • 4.8.6 GE Healthcare Radiopharmaceutical Revenue by Application
  • 4.8.7 GE Healthcare Radiopharmaceutical Revenue by Geographic Area
  • 4.8.8 GE Healthcare Recent Development
• 4.9 China Isotope & Radiation
  • 4.9.1 China Isotope & Radiation Corporation Information
  • 4.9.2 China Isotope & Radiation Description, Business Overview
  • 4.9.3 China Isotope & Radiation Radiopharmaceutical Products Offered
  • 4.9.4 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.9.5 China Isotope & Radiation Radiopharmaceutical Revenue by Product
  • 4.9.6 China Isotope & Radiation Radiopharmaceutical Revenue by Application
  • 4.9.7 China Isotope & Radiation Radiopharmaceutical Revenue by Geographic Area
  • 4.9.8 China Isotope & Radiation Recent Development
• 4.10 Jubilant Pharma
  • 4.10.1 Jubilant Pharma Corporation Information
  • 4.10.2 Jubilant Pharma Description, Business Overview
  • 4.10.3 Jubilant Pharma Radiopharmaceutical Products Offered
  • 4.10.4 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.10.5 Jubilant Pharma Radiopharmaceutical Revenue by Product
  • 4.10.6 Jubilant Pharma Radiopharmaceutical Revenue by Application
  • 4.10.7 Jubilant Pharma Radiopharmaceutical Revenue by Geographic Area
  • 4.10.8 Jubilant Pharma Recent Development
• 4.11 Eli Lilly
  • 4.11.1 Eli Lilly Corporation Information
  • 4.11.2 Eli Lilly Description, Business Overview
  • 4.11.3 Eli Lilly Radiopharmaceutical Products Offered
  • 4.11.4 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.11.5 Eli Lilly Radiopharmaceutical Revenue by Product
  • 4.11.6 Eli Lilly Radiopharmaceutical Revenue by Application
  • 4.11.7 Eli Lilly Radiopharmaceutical Revenue by Geographic Area
  • 4.11.8 Eli Lilly Recent Development
• 4.12 Advanced Accelerator Applications
  • 4.12.1 Advanced Accelerator Applications Corporation Information
  • 4.12.2 Advanced Accelerator Applications Description, Business Overview
  • 4.12.3 Advanced Accelerator Applications Radiopharmaceutical Products Offered
  • 4.12.4 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.12.5 Advanced Accelerator Applications Radiopharmaceutical Revenue by Product
  • 4.12.6 Advanced Accelerator Applications Radiopharmaceutical Revenue by Application
  • 4.12.7 Advanced Accelerator Applications Radiopharmaceutical Revenue by Geographic Area
  • 4.12.8 Advanced Accelerator Applications Recent Development
• 4.13 SIEMENS
  • 4.13.1 SIEMENS Corporation Information
  • 4.13.2 SIEMENS Description, Business Overview
  • 4.13.3 SIEMENS Radiopharmaceutical Products Offered
  • 4.13.4 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.13.5 SIEMENS Radiopharmaceutical Revenue by Product
  • 4.13.6 SIEMENS Radiopharmaceutical Revenue by Application
  • 4.13.7 SIEMENS Radiopharmaceutical Revenue by Geographic Area
  • 4.13.8 SIEMENS Recent Development
• 4.14 Dongcheng
  • 4.14.1 Dongcheng Corporation Information
  • 4.14.2 Dongcheng Description, Business Overview
  • 4.14.3 Dongcheng Radiopharmaceutical Products Offered
  • 4.14.4 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.14.5 Dongcheng Radiopharmaceutical Revenue by Product
  • 4.14.6 Dongcheng Radiopharmaceutical Revenue by Application
  • 4.14.7 Dongcheng Radiopharmaceutical Revenue by Geographic Area
  • 4.14.8 Dongcheng Recent Development
• 4.15 Navidea
  • 4.15.1 Navidea Corporation Information
  • 4.15.2 Navidea Description, Business Overview
  • 4.15.3 Navidea Radiopharmaceutical Products Offered
  • 4.15.4 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 4.15.5 Navidea Radiopharmaceutical Revenue by Product
  • 4.15.6 Navidea Radiopharmaceutical Revenue by Application
  • 4.15.7 Navidea Radiopharmaceutical Revenue by Geographic Area
  • 4.15.8 Navidea Recent Development

5 Breakdown Data by Type

• 5.1 Global Radiopharmaceutical Sales by Type (2015-2026)
  • 5.1.1 Global Radiopharmaceutical Sales by Type (2015-2020)
  • 5.1.2 Global Radiopharmaceutical Sales Forecast by Type (2021-2026)
  • 5.1.3 Global Radiopharmaceutical Sales Market Share by Type (2015-2026)
• 5.2 Global Radiopharmaceutical Revenue Forecast by Type (2015-2026)
  • 5.2.1 Global Radiopharmaceutical Revenue by Type (2015-2020)
  • 5.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2021-2026)
  • 5.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2015-2026)
• 5.3 Radiopharmaceutical Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

• 6.1 Global Radiopharmaceutical Sales by Application (2015-2026)
  • 6.1.1 Global Radiopharmaceutical Sales by Application (2015-2020)
  • 6.1.2 Global Radiopharmaceutical Sales Forecast by Application (2021-2026)
  • 6.1.3 Global Radiopharmaceutical Sales Market Share by Application (2015-2026)
• 6.2 Global Radiopharmaceutical Revenue Forecast by Application (2015-2026)
  • 6.2.1 Global Radiopharmaceutical Revenue by Application (2015-2020)
  • 6.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2021-2026)
  • 6.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2015-2026)
• 6.3 Radiopharmaceutical Average Selling Price (ASP) by Application (2015-2026)

7 North America

• 7.1 North America Radiopharmaceutical Market Size YoY Growth 2015-2026
• 7.2 North America Radiopharmaceutical Market Facts & Figures by Country
  • 7.2.1 North America Radiopharmaceutical Sales by Country (2015-2026)
  • 7.2.2 North America Radiopharmaceutical Revenue by Country (2015-2026)
• 7.3 North America Radiopharmaceutical Sales by Type
• 7.4 North America Radiopharmaceutical Sales by Application

8 Asia-Pacific

• 8.1 Asia-Pacific Radiopharmaceutical Market Size YoY Growth 2015-2026
• 8.2 Asia-Pacific Radiopharmaceutical Market Facts & Figures by Region
  • 8.2.1 Asia-Pacific Radiopharmaceutical Sales by Region (2015-2026)
  • 8.2.2 Asia-Pacific Radiopharmaceutical Revenue by Region (2015-2026)
• 8.3 Asia-Pacific Radiopharmaceutical Sales by Type
• 8.4 Asia-Pacific Radiopharmaceutical Sales by Application

9 Europe

• 9.1 Europe Radiopharmaceutical Market Size YoY Growth 2015-2026
• 9.2 Europe Radiopharmaceutical Market Facts & Figures by Country
  • 9.2.1 Europe Radiopharmaceutical Sales by Country (2015-2026)
  • 9.2.2 Europe Radiopharmaceutical Revenue by Country (2015-2026)
• 9.3 Europe Radiopharmaceutical Sales by Type
• 9.4 Europe Radiopharmaceutical Sales by Application

10 Latin America

• 10.1 Latin America Radiopharmaceutical Market Size YoY Growth 2015-2026
• 10.2 Latin America Radiopharmaceutical Market Facts & Figures by Country
  • 10.2.1 Latin America Radiopharmaceutical Sales by Country (2015-2026)
  • 10.2.2 Latin America Radiopharmaceutical Revenue by Country (2015-2026)
• 10.3 Latin America Radiopharmaceutical Sales by Type
• 10.4 Latin America Radiopharmaceutical Sales by Application

11 Middle East and Africa

• 11.1 Middle East and Africa Radiopharmaceutical Market Size YoY Growth 2015-2026
• 11.2 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
  • 11.2.1 Middle East and Africa Radiopharmaceutical Sales by Country (2015-2026)
  • 11.2.2 Middle East and Africa Radiopharmaceutical Revenue by Country (2015-2026)
• 11.3 Middle East and Africa Radiopharmaceutical Sales by Type
• 11.4 Middle East and Africa Radiopharmaceutical Sales by Application

12 Supply Chain and Sales Channel Analysis

• 12.1 Radiopharmaceutical Supply Chain Analysis
• 12.2 Radiopharmaceutical Key Raw Materials and Upstream Suppliers
• 12.3 Radiopharmaceutical Clients Analysis
• 12.4 Radiopharmaceutical Sales Channel and Sales Model Analysis
  • 12.4.1 Radiopharmaceutical Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 12.4.2 Radiopharmaceutical Distribution Channel Analysis: Online Sales VS Offline Sales
  • 12.4.3 Radiopharmaceutical Distributors

13 Market Dynamics

• 13.1 Radiopharmaceutical Market Drivers
• 13.2 Radiopharmaceutical Market Opportunities
• 13.3 Radiopharmaceutical Market Challenges
• 13.4 Radiopharmaceutical Market Restraints
• 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details